Delivery Order SPE2DB22D1202-SPE2DB25FUVJ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $39,293.33 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens on November 18, 2025. This firm fixed-price, non-set-aside contract calls for delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with a completion date of November 19, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $10,128.30 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens. This is a firm fixed-price delivery order with a completion date of August 21, 2025, issued under a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with...
- The Defense Logistics Agency awarded a delivery order valued at $18,697.47 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on June 27, 2025, with a completion date of June 30, 2025. This competitive award uses firm fixed pricing and carries no set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a $3,558.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $14,645.91 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on September 9, 2025, with completion targeted for September 10, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $10,463.69 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on May 27, 2025. This firm fixed-price contract, which must be completed by May 28, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,537.40 on June 2, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,178.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on May 30, 2025, with completion targeted for June 2, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $28,560.25 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on November 20, 2025. This is a firm fixed-price delivery order with an ultimate completion date of November 21, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,143.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on September 5, 2025, with completion targeted for September 8, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime IDC running through December 2026. The product will be performed at the...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FUVJ7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $29,010.80 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens on March 18, 2025, with completion targeted for March 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company holds a $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical running through December 2026, which enables the supply of comprehensive pharmaceutical products and medical supplies globally. This delivery order for Zepbound exemplifies AmerisourceBergen's extensive portfolio of federal pharmaceutical deliveries, which span diabetes medications, specialty treatments, and other therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.0k | 3/18/25 |